Simple test could predict response to anthracycline chemotherapy for patients with triple negative breast cancer

A new biomarker could predict whether a common type of chemotherapy will be effective for patients with triple negative breast cancer and help to personalise their treatment, a study published in BMC Cancer has found.  The study found that breast...

More From BioPortfolio on "Simple test could predict response to anthracycline chemotherapy for patients with triple negative breast cancer"